The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma
2 विचारों
• 07/18/23
0
0
एम्बेड
administrator
ग्राहकों
Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां